Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers

References

• World Health Organization Cancer2018 Available from: http://www.who.int/mediacentre/factsheets/fs297/enAccessed February 13, 2018
   Google Scholar
• Pérez-HerreroEFernández-MedardeAAdvanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapyEur J Pharm Biopharm201593527925813885
   PubMed Web of Science ®Google Scholar
• Ghaz-JahanianMAAbbaspour-AghdamFAnarjanNBerenjianAJafarizadeh-MalmiriHApplication of chitosan-based nanocarriers in tumor-targeted drug deliveryMol Biotechnol20155720121825385004
   PubMed Web of Science ®Google Scholar
• TannockIFLeeCMTunggalJKCowanDSEgorinMJLimited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapyClin Cancer Res2002887888411895922
   PubMed Web of Science ®Google Scholar
• SutradharKBAminMLNanotechnology in cancer drug delivery and selective targetingISRN Nanotechnology20142014939378
   Google Scholar
• GuptaAKaurCDSarafSSarafSTargeting of herbal bioactives through folate receptors: a novel concept to enhance intracellular drug delivery in cancer therapyJ Recept Signal Transduct Res20173731432328095746
   PubMed Web of Science ®Google Scholar
• LundstromKCancer therapy applying viral nanoparticlesKhudyakovYPumpensPViral NanotechnologyBoca RatonTaylor & Francis2015455466
   Google Scholar
• BakerJRDendrimer-based nanoparticles for cancer therapyHematology Am Soc Hematol Educ Program200970871920008257
   PubMedGoogle Scholar
• JainSHirstDGO’SullivanJMGold nanoparticles as novel agents for cancer therapyBr J Radiol20128510111322010024
   PubMed Web of Science ®Google Scholar
• PandeyHRaniRAgarwaVLiposome and their [sic] applications in cancer therapyBraz Arch Biol Technol201659e16150477
   Web of Science ®Google Scholar
• BondìMLCraparoEFGiammonaGNanostructured lipid carriers-containing anticancer compounds: preparation, characterization, and cytotoxicity studiesDrug Deliv200714616717364869
   PubMed Web of Science ®Google Scholar
• OerlemansCBultWBosMStormGNijsenJFHenninkWEPolymeric micelles in anticancer therapy: targeting, imaging and triggered releasePharm Res2010272569258920725771
   PubMed Web of Science ®Google Scholar
• ParveenSSahooSKPolymeric nanoparticles for cancer therapyJ Drug Target20081610812318274932
   PubMed Web of Science ®Google Scholar
• GaoHYangZZhangSLigand modified nanoparticles increases [sic] cell uptake, alters endocytosis and elevates glioma distribution and internalizationSci Rep20133253423982586
   PubMed Web of Science ®Google Scholar
• TorchilinVPBensonHTothICell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene deliveryBiopolymers20089060461018381624
   PubMed Web of Science ®Google Scholar
• ZhangXXEdenHSChenXPeptides in cancer nanomedicine: drug carriers, targeting ligands and protease substratesJ Control Release201215921322056916
   PubMed Web of Science ®Google Scholar
• DissanayakeSDennyWAGamageSSarojiniVRecent developments in anticancer drug delivery using cell penetrating and tumor targeting peptidesJ Control Release2017250627628167286
   PubMed Web of Science ®Google Scholar
• LiuZDelavanBRobertsRTongWLessons learned from two decades of anticancer drugsTrends Pharmacol Sci20173885287228709554
   PubMed Web of Science ®Google Scholar
• PrabhakarUMaedaHJainRKChallenges and key considerations of the enhanced permeability and retention effect for nanomedi-cine drug delivery in oncologyCancer Res2013732412241723423979
   PubMed Web of Science ®Google Scholar
• UlbrichKHoláKSubrVBakandritsosATučekJZbořilRTargeted drug delivery with polymers and magnetic nanoparticlesChem Rev20161165338543127109701
   PubMed Web of Science ®Google Scholar
• ThankiKKushwahVJainSRecent advances in tumor targeting approachesDevarajanPVJainSTargeted Drug Delivery: Concepts and DesignHeidelbergSpringer201541112
   Google Scholar
• YuXTraseIRenMDuvalKGuoXChenZDesign of nanoparticle-based carriers for targeted drug deliveryJ Nanomater20162016108725027398083
   PubMed Web of Science ®Google Scholar
• XuXHoWZhangXBertrandNFarokhzadOCancer nanomedicine: from targeted delivery to combination therapyTrends Mol Med20152122323225656384
   PubMed Web of Science ®Google Scholar
• FangJNakamuraHMaedaHThe EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effectAdv Drug Deliv Rev20116313615120441782
   PubMed Web of Science ®Google Scholar
• BahramiBHojjat-FarsangiMMohammadiHNanoparticles and targeted drug delivery in cancer therapyImmunol Lett2017190648328760499
   PubMed Web of Science ®Google Scholar
• KunjachanSRychlikBStormGKiesslingFLammersTMultidrug resistance: physiological principles and nanomedical solutionsAdv Drug Deliv Rev2013651852186524120954
   PubMed Web of Science ®Google Scholar
• YildizIShuklaSSteinmetzNFApplications of viral nanoparticles in medicineCurr Opin Biotechnol20112290190821592772
   PubMed Web of Science ®Google Scholar
• GuptaCPrakashDGuptaSCancer treatment with nano-diamondsFront Biosci (Schol Ed)20179627027814575
   PubMedGoogle Scholar
• YaoVJD’AngeloSButlerKSLigand-targeted theranostic nanomedicines against cancerJ Control Release201624026728626772878
   PubMed Web of Science ®Google Scholar
• de OliveiraROde Santa MariaLCBarrattGNanomedicine and its applications to the treatment of prostate cancerAnn Pharm Fr20147230331625220226
   PubMedGoogle Scholar
• BabaeiMEshghiHAbnousKRahimizadehMRamezaniMPromising gene delivery system based on polyethylenimine-modified silica nanoparticlesCancer Gene Ther20172415616428128214
   PubMed Web of Science ®Google Scholar
• PetrosRADeSimoneJMStrategies in the design of nanoparticles for therapeutic applicationsNat Rev Drug Discov2010961562720616808
   PubMed Web of Science ®Google Scholar
• YameenBChoiWVilosCSwamiAShiJFarokhzadOCInsight into nanoparticle cellular uptake and intracellular targetingJ Control Release201419048549924984011
   PubMed Web of Science ®Google Scholar
• ZhongYMengFDengCZhongZLigand-directed active tumor- targeting polymeric nanoparticles for cancer chemotherapyBiomacromolecules2014151955196924798476
   PubMed Web of Science ®Google Scholar
• JaraczSChenJKuznetsovaLVOjimaIRecent advances in tumor-targeting anticancer drug conjugatesBioorg Med Chem2005135043505415955702
   PubMed Web of Science ®Google Scholar
• ThayerAMImproving peptidesChem Eng News2011891320
   Web of Science ®Google Scholar
• DavidAPeptide ligand-modified nanomedicines for targeting cells at the tumor microenvironmentAdv Drug Deliv Rev201711912014228506743
   PubMed Web of Science ®Google Scholar
• KarraNBenitaSThe ligand nanoparticle conjugation approach for targeted cancer therapyCurr Drug Metab201213224121892918
   PubMed Web of Science ®Google Scholar
• GuidottiGBrambillaLRossiDCell-penetrating peptides: from basic research to clinicsTrends Pharmacol Sci20173840642428209404
   PubMed Web of Science ®Google Scholar
• MeloniBPCraigAJMilechNHopkinsRMWattPMKnuckeyNWThe neuroprotective efficacy of cell-penetrating peptides TAT, pen-etratin, Arg-9, and Pep-1 in glutamic acid, kainic acid, and in vitro ischemia injury models using primary cortical neuronal culturesCell Mol Neurobiol20143417318124213248
   PubMed Web of Science ®Google Scholar
• MaCYinGYouFA specific cell-penetrating peptide induces apoptosis in SKOV3 cells by down-regulation of Bcl-2Biotechnol Lett2013351791179723797900
   PubMed Web of Science ®Google Scholar
• KristensenMBirchDNielsenHMApplications and challenges for use of cell-penetrating peptides as delivery vectors for peptide and protein cargosInt J Mol Sci201617E18526840305
   PubMed Web of Science ®Google Scholar
• HsiehTHA novel cell-penetrating peptide suppresses breast tumorigenesis by inhibiting β-catenin/LEF-1 signalingSci Rep201661915626750754
   PubMed Web of Science ®Google Scholar
• MehtaRYamadaTTaylorBNA cell penetrating peptide derived from azurin inhibits angiogenesis and tumor growth by inhibiting phosphorylation of VEGFR-2, FAK and AktAngiogenesis20111435536921667138
   PubMed Web of Science ®Google Scholar
• KristensenMde GrootAMBerthelsenJFranzykHSijtsANielsenHMConjugation of cell-penetrating peptides to parathyroid hormone affects its structure, potency, and transepithelial permeationBioconjug Chem20152647748825611217
   PubMed Web of Science ®Google Scholar
• SunWFletcherDvan HeeckerenCRDavisPBNon-covalent ligand conjugation to biotinylated DNA nanoparticles using TAT peptide genetically fused to monovalent streptavidinJ Drug Target20122067869022845840
   PubMed Web of Science ®Google Scholar
• CopoloviciDMLangelKEristeELangelUCell-penetrating peptides: design, synthesis, and applicationsASC Nano2014819721994
   Web of Science ®Google Scholar
• JafariSDizajSMAdibkiaKCell-penetrating peptides and their analogues as novel nanocarriers for drug deliveryBioimpacts2015510311126191505
   PubMed Web of Science ®Google Scholar
• MillettiFCell-penetrating peptides: classes, origin, and current landscapeDrug Discov Today20121785086022465171
   PubMed Web of Science ®Google Scholar
• WangFWangYZhangXZhangWGuoSJinFRecent progress of cell-penetrating peptides as new carriers for intracellular cargo deliveryJ Control Release201417412613624291335
   PubMed Web of Science ®Google Scholar
• RegbergJSrimaneeALangelUApplications of cell-penetrating peptides for tumor targetingPharmaceuticals (Basel)20125991100724280701
   PubMedGoogle Scholar
• PalmCJayamanneMKjellanderMHällbrinkMPeptide degradation is a critical determinant for cell-penetrating peptide uptakeBiochim Biophys Acta200717681769177617499577
   PubMed Web of Science ®Google Scholar
• FominayaJBravoJRebolloAStrategies to stabilize cell penetratingTher Deliv201561171119426448473
   PubMedGoogle Scholar
• ChorevMGoodmanMRecent developments in retro peptides and proteins: an ongoing topochemical explorationTrends Biotechnol1995134384457546569
   PubMed Web of Science ®Google Scholar
• VaissièreAAldrianGKonateKA retro-inverso cell-penetrating peptide for siRNA deliveryJ Nanobiotechnology2017153428454579
   PubMed Web of Science ®Google Scholar
• HolmTRäägelHAndaloussiSERetro-inversion of certain cell-penetrating peptides causes severe cellular toxicityBiochim Biophys Acta201118081544155121070744
   PubMed Web of Science ®Google Scholar
• HornMReichartFNatividad-TietzSDiazDNeundorfITuning the properties of a novel short cell-penetrating peptide by intramolecular cyclization with a triazole bridgeChem Commun (Cab)20165222612264
   PubMed Web of Science ®Google Scholar
• Lättig-TünnemannGPrinzMHoffmannDBackbone rigidity and static presentation of guanidinium groups increases cellular uptake of arginine-rich cell-penetrating peptidesNat Commun2011245321878907
   PubMed Web of Science ®Google Scholar
• FriedlerAFriedlerDLuedtkeNWTorYLoyterAGilonCDevelopment of a functional backbone cyclic mimetic of the HIV-1 Tat arginine-rich motifJ Biol Chem2000275237832378910764789
   PubMed Web of Science ®Google Scholar
• ReissmannSCell penetration: scope and limitations by the application of cell-penetrating peptidesJ Pept Sci20142076078425112216
   PubMed Web of Science ®Google Scholar
• DietzGPBahrMDelivery of bioactive molecules into the cell: the Trojan horse approachMol Cell Neurosci2004278513115485768
   PubMed Web of Science ®Google Scholar
• DurzyńskaJPrzysieckaLNawrotRViral and other cell-penetrating peptides as vectors of therapeutic agents in medicineJ Pharmacol Exp Ther2015354324225922342
   PubMed Web of Science ®Google Scholar
• VerdurmenWPBrockRBiological responses towards cationic peptides and drug carriersTrends Pharmacol Sci20113211612421167610
   PubMed Web of Science ®Google Scholar
• El-AndaloussiSJärverPJohanssonHJCargo-dependent cytotoxicity and delivery efficacy of cell-penetrating peptides: a comparative studyBiochem J200740728529217627607
   PubMed Web of Science ®Google Scholar
• UusnaJLangelKLangelUToxicity, Immunogenicity, uptake, and kineticsLangelUCell-Penetrating Peptides: Methods and Protocols2nd edHeidelbergSpringer2015133148
   Google Scholar
• SuhorutsenkoJOskolkovNArukuuskPCell-penetrating peptides, PepFects, show no evidence of toxicity and immunogenicity in vitro and in vivoBioconjug Chem2011222255226221978260
   PubMed Web of Science ®Google Scholar
• KilkKMahlapuuRSoometsULangelUAnalysis of in vitro toxicity of five cell-penetrating peptides by metabolic profilingToxicology2009265879519799958
   PubMed Web of Science ®Google Scholar
• AguileraTATimmersMMOlsonESJiangTTsienRYSystemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptidesIntegr Biol (Camb)2009137138120023744
   PubMed Web of Science ®Google Scholar
• MoschosSAJonesSWPerryMMLung delivery studies using siRNA conjugated to TAT48–60 and penetratin reveal peptide induced reduction in gene expression and induction of innate immunityBioconjug Chem2007181450145917711319
   PubMed Web of Science ®Google Scholar
• CarterELauCYToshDWardSGMrsnyRJCell penetrating peptides fail to induce an innate immune response in epithelial cells in vitro: implications for continued therapeutic useEur J Pharm Biopharm201385121923958314
   PubMed Web of Science ®Google Scholar
• CardozoAKBuchillierVMathieuMCell-permeable peptides induce dose- and length-dependent cytotoxic effectsBiochim Biophys Acta200717682222223417626783
   PubMed Web of Science ®Google Scholar
• YenHJHsuSHTsaiCLCytotoxicity and immunological response of gold and silver nanoparticles of different sizesSmall200951553156119326357
   PubMed Web of Science ®Google Scholar
• HeXLiJAnSJiangCpH-sensitive drug-delivery systems for tumor targetingTher Deliv201341499151024304248
   PubMedGoogle Scholar
• OlsonEIn vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancerIntegr Biol (Camb)2009138239320023745
   PubMed Web of Science ®Google Scholar
• MacEwanSRChilkotiAHarnessing the power of cell-penetrating peptides: activatable carriers for targeting systemic delivery of cancer therapeutics and imaging agentsWiley Interdiscip Rev Nanomed Nanobiotechnol20135314822977001
   PubMed Web of Science ®Google Scholar
• KurrikofKGestinMLangelURecent in vivo advances in cell-penetrating peptide-assisted drug deliveryExpert Opin Drug Deliv20151337338726634750
   PubMed Web of Science ®Google Scholar
• JinEZhangBSunXAcid-active cell-penetrating peptides for in vivo tumor-targeted drug deliveryJ Am Chem Soc201313593394023253016
   PubMed Web of Science ®Google Scholar
• ChengHZhuJYXuXDActivable cell-penetrating peptide conjugated prodrug for tumor targeted drug deliveryACS Appl Mater Interfaces20157160611606926161578
   PubMed Web of Science ®Google Scholar
• RegbergJVasconcelosLMadaniFLangelUHällbrinkMpH-responsive PepFect cell-penetrating peptidesInt J Pharm2016501323826821060
   PubMedGoogle Scholar
• ZhaoBXZhaoYHuangYThe efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing pacli-taxelBiomaterials2012332508252022197569
   PubMed Web of Science ®Google Scholar
• ZhangQTangJFuLA pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery systemBiomaterials2013347980799323891517
   PubMed Web of Science ®Google Scholar
• YaoJMaYZhangWDesign of new acid-activated cell-penetrating peptides for tumor drug deliveryPeerJ20175e342928603674
   PubMed Web of Science ®Google Scholar
• LeeDNohIYooJRejinoldNSKimYCpH-controllable cell-penetrating polypeptide that exhibits cancer targetingActa Biomater20175718719628528116
   PubMed Web of Science ®Google Scholar
• HeHSunLYeJEnzyme-triggered, cell penetrating peptide-mediated delivery of anti-tumor agentsJ Control Release2016240677626514292
   PubMed Web of Science ®Google Scholar
• van DuijnhovenSMRobillardMSNicolayKGrüllHTumor targeting of MMP-2/9 activatable cell-penetrating imaging probes is caused by tumor-independent activationJ Nucl Med20115227928621233187
   PubMed Web of Science ®Google Scholar
• ShiNQGaoWXiangBQiXREnhancing cellular uptake of activable cell-penetrating peptide-doxorubicin conjugate by enzymatic cleavageInt J Nanomedicine201271613162122619516
   PubMed Web of Science ®Google Scholar
• GaoHZhangSCaoSYangZPangZJiangXAngiopep-2 and activatable cell-penetrating peptide dual-functionalized nanoparticles for systemic glioma-targeting deliveryMol Pharm2014112755276324983928
   PubMed Web of Science ®Google Scholar
• XiaHGuGHuQActivatable cell penetrating peptide-conjugated nanoparticles with enhanced permeability for site-specific targeting delivery of anticancer drugBioconjug Chem20132441943023350619
   PubMed Web of Science ®Google Scholar
• ZhuLWangTPercheFTaigindATorchilinVPEnhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moietyProc Natl Acad Sci U S A2013110170471705224062440
   PubMed Web of Science ®Google Scholar
• YooJRejinoldNSLeeDJonSKimYCProtease-activatable cell-penetrating peptide possessing ROS-triggered phase transition for enhanced cancer therapyJ Control Release20172648910128842316
   PubMed Web of Science ®Google Scholar
• WhitneyMCrispJLOlsonESParallel in vivo and in vitro selection using phage display identifies protease-dependent tumor-targeting peptidesJ Biol Chem2010285225322254120460372
   PubMed Web of Science ®Google Scholar
• LiJLiuFShaoQEnzyme-responsive cell-penetrating peptide conjugated mesoporous silica quantum dot nanocarriers for controlled release of nucleus-targeted drug molecules and real-time intracellular fluorescence imaging of tumor cellsAdv Healthc Mater201431230123924550203
   PubMed Web of Science ®Google Scholar
• BraunGBSugaharaKNYuOMUrokinase-controlled tumor penetrating peptideJ Control Release201623218819527106816
   PubMed Web of Science ®Google Scholar
• ZhangDWangaJXuDCell-penetrating peptides as noninvasive transmembrane vectors for the development of novel multifunctional drug-delivery systemsJ Control Release201622913013926993425
   PubMed Web of Science ®Google Scholar
• ShamayYAdarLAshkenasyGDavidALight induced drug delivery into cancer cellsBiomaterials2011321377138621074848
   PubMed Web of Science ®Google Scholar
• LinWXieXYangYEnhanced small interfering RNA delivery into cells by exploiting the additive effect between photo-sensitive peptides and targeting ligandsJ Pharm Pharmacol2015671215123125880614
   PubMed Web of Science ®Google Scholar
• YangYXieXYangYZhangHMeiXPhoto-responsive and NGR-mediated multifunctional nanostructured lipid carrier for tumor-specific therapyJ Pharm Sci20151041328133925630979
   PubMed Web of Science ®Google Scholar
• YangYYangYXieXDual-modified liposomes with a two-photon-sensitive cell penetrating peptide and NGR ligand for siRNA targeting deliveryBiomaterials201548849625701034
   PubMed Web of Science ®Google Scholar
• WalkerLRRyuJSPerkinsEFusion of cell-penetrating peptides to thermally responsive biopolymer improves tumor accumulation of p21 peptide in a mouse model of pancreatic cancerDrug Des Devel Ther2014816491658
   PubMed Web of Science ®Google Scholar
• MitchellKSvensonKBLongmateWMSuppression of integrin α3β1 in breast cancer cells reduces cyclooxygenase-2 gene expression and inhibits tumorigenesis, invasion, and cross-talk to endothelial cellsCancer Res2010706359636720631072
   PubMed Web of Science ®Google Scholar
• LaakkonenPVuorinenKHoming peptides as targeted delivery vehiclesIntegr Biol (Camb)2010232633720657951
   PubMed Web of Science ®Google Scholar
• LiZJChoCPeptides as targeting probes against tumor vasculature for diagnosis and drug deliveryJ Transl Med201210S123046982
   PubMed Web of Science ®Google Scholar
• ArapWPasqualiniRRuoslahtiECancer treatment by targeted drug delivery to tumor vasculature in a mouse modelScience19982793773809430587
   PubMed Web of Science ®Google Scholar
• LuLQiHZhuJVascular-homing peptides for cancer therapyBiomed Pharmacother20179218719528544932
   PubMed Web of Science ®Google Scholar
• ChristianSPilchJAkermanMEPorkkaKLaakkonenPRuoslahtiENucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vesselJ Cell Biol200316387187814638862
   PubMed Web of Science ®Google Scholar
• WangCWangXZhongXThe antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivoInt J Nanomedicine2015102229224825834435
   PubMed Web of Science ®Google Scholar
• LiZJWuWKNgSSA novel peptide specifically targeting the vasculature of orthotopic colorectal cancer for imaging detection and drug deliveryJ Control Release201014829230220854857
   PubMed Web of Science ®Google Scholar
• LaakkonenPAkermanMEBiliranHAntitumor activity of a homing peptide that targetsProc Natl Acad Sci U S A20041019381938615197262
   PubMed Web of Science ®Google Scholar
• FogalVZhangLKrajewskiSRuoslahtiEMitochondrial/cell surface protein p32/gC1qR as a molecular target in tumor cells and tumor stromaCancer Res2008687210721818757437
   PubMed Web of Science ®Google Scholar
• SeleciDASeleciMStahlFScheperTTumor homing and penetrating peptide-conjugated niosomes as multi-drug carriers for tumor-targeted drug deliveryRSC Adv201773337833384
   Web of Science ®Google Scholar
• HeXNaMHKimJSA novel peptide probe for imaging and targeted delivery of liposomal doxorubicin to lung tumorMol Pharm2011843043821222482
   PubMedGoogle Scholar
• TeesaluTSugaharaKKotamrajuVRuoslahtiEC-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetrationProc Natl Acad Sci U S A2009106161571616219805273
   PubMed Web of Science ®Google Scholar
• RuoslahtiETumor penetrating peptides for improved drug deliveryAdv Drug Deliv Rev2017110–111312
   PubMed Web of Science ®Google Scholar
• MyrbergHZhangLMäeMLangelUDesign of a tumor-homing cell-penetrating peptideBioconjug Chem200819707518001077
   PubMed Web of Science ®Google Scholar
• BolhassaniAPotential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancerBiochim Biophys Acta2011181623224621840374
   PubMed Web of Science ®Google Scholar
• MäeMMyrbergHEl-AndaloussiSLangelUDesign of a tumor homing cell-penetrating peptide for drug deliveryInt J Pept Res Ther2009151115
   Web of Science ®Google Scholar
• FanLQDuGXLiPFLiMWSunYZhaoLMImproved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptideBiomed Pharmacother2016841783179127899251
   PubMed Web of Science ®Google Scholar
• GaoHZhangaQYangaYJiangXHeQTumor homing cell penetrating peptide decorated nanoparticles used for enhancing tumor targeting delivery and therapyInt J Pharm201547824025025448586
   PubMedGoogle Scholar
• LimKJSungBHShinJRA cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cellsPLoS One20138e6608423776609
   PubMed Web of Science ®Google Scholar
• ShengYYouYChenYDual-targeting hybrid peptide-conjugated doxorubicin for drug resistance reversal in breast cancerInt J Pharm201651211327521706
   PubMed Web of Science ®Google Scholar
• LelleMFreidelCKaloyanovaSOvercoming drug resistance by cell-penetrating peptide-mediated delivery of a doxorubicin dimer with high DNA-binding affinityEur J Med Chem201713033634528273560
   PubMed Web of Science ®Google Scholar
• FengCRuiMShenHTumor-specific delivery of doxorubicin through conjugation of pH-responsive peptide for overcoming drug resistance in cancerInt J Pharm201752832233328606508
   PubMed Web of Science ®Google Scholar
• CraggGMNewmanDJPlants as a source of anti-cancer agentsJ Ethnopharmacol2005100727916009521
   PubMed Web of Science ®Google Scholar
• SoloweyELichtensteinMSallonSPaavilainenHSoloweyELorberboum-GalskiHEvaluating medicinal plants for anticancer activityScientificWorldJournal2014201472140225478599
   PubMedGoogle Scholar
• AhmadRAhmadNNaqviAAShehzadAAl-GhamdiMSRole of traditional Islamic and Arabic plants in cancer therapyJ Tradit Complement Med2017719520428417090
   PubMedGoogle Scholar
• ShahUShahRAcharyaSAcharyaNNovel anticancer agents from plant sourcesChin J Nat Med2013111623
   Web of Science ®Google Scholar
• KhazirJMirBAPilcherLRileyDLRole of plants in anticancer drug discoveryPhytochem Lett20147173181
   Web of Science ®Google Scholar
• OkounevaTHillBTWilsonLJordanMAThe effects of vinflunine, vinorelbine, and vinblastine on centromere dynamicsMol Cancer Ther2003242743612748304
   PubMed Web of Science ®Google Scholar
• SimoensCLardonFPauwelsBComparative study of the radiosensitising and cell cycle effects of vinflunine and vinorelbine, in-vitroBMC Cancer200886518312675
   PubMed Web of Science ®Google Scholar
• ThapaRKKhanGMParajuli-BaralKThapaPHerbal medicine incorporated nanoparticles: advancements in herbal treatmentAsian J Biomed Pharm Sci20133714
   Google Scholar
• WallMEWaniMCCookCEPlant antitumor agents – I: the isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminataJ Am Chem Soc19668838883890
   Web of Science ®Google Scholar
• PrakashOKumarAKumarPAnticancer potential of plants and natural productsAm J Pharmacol Sci20131104115
   Google Scholar
• SaeidniaSAbdollahiMPerspective study on anticancer drugs from natural originInt J Pharmacol20141090108
   Google Scholar
• DhillonNAggarwalBBNewmanRAPhase II trial of curcumin in patients with advanced pancreatic cancerClin Cancer Res2008144491449918628464
   PubMed Web of Science ®Google Scholar
• TeitenMHGaaschtFDicatoMDiederichMAnticancer bioactivity of compounds from medicinal plants used in European medieval traditionsBiochem Pharmacol2013861239124723973807
   PubMed Web of Science ®Google Scholar
• TanWLuJHuangMAnti-cancer natural products isolated from Chinese medicinal herbsChin Med201162721777476
   PubMed Web of Science ®Google Scholar
• BishayeeASethiGBioactive natural products in cancer prevention and therapy: progress and promiseSemin Cancer Biol201640–4113
   PubMed Web of Science ®Google Scholar
• HerstPMDavisJENeesonPBerridgeMVRitchieDSThe anticancer drug, phenoxodiol, kills primary myeloid and lymphoid leukemic blasts and rapidly proliferating T cellsHaematologica20099492893419535345
   PubMed Web of Science ®Google Scholar
• SaeidniaSAbdollahiMPerspective study on anticancer drugs from natural originInt J Pharmacol20141090108
   Google Scholar
• AodahAPavlikAKarlageKMyrdalPBPreformulation studies on piperlonguminePLoS One201611e015170726982320
   PubMed Web of Science ®Google Scholar
• SaklaniAKuttySKPlant-derived compounds in clinical trialsDrug Discov Today20081316117118275914
   PubMed Web of Science ®Google Scholar
• WaniWTarawadiKKaul-GhanekarRNanocarriers for delivery of herbal based drugs in breast cancer: an overviewJ Nano Res2015342940
   Web of Science ®Google Scholar
• AnandPKunnumakkaraANewmanRAggarwalBBBioavailability of curcumin: problems and promisesMol Pharm2007480781817999464
   PubMed Web of Science ®Google Scholar
• KangarlouSRamezanpourSBalalaieSMohammadiSRHaririanICurcumin-loaded nanoliposomes linked to homing peptides for integrin targeting and neuropilin-1-mediated internalizationPharm Biol20175527728527937055
   PubMed Web of Science ®Google Scholar
• SimionVStanDConstantinescuCAConjugation of curcumin-loaded lipid nanoemulsions with cell-penetrating peptides increases their cellular uptake and enhances the anti-inflammatory effects in endothelial cellsJ Pharm Pharmacol20166819520726748549
   PubMed Web of Science ®Google Scholar
• DasKNimushakaviSChaudhuriADasPKAn integrin-targeting RGDK-tagged nanocarrier: anticancer efficacy of loaded curcuminChemMedChem20178738750
   Google Scholar
• LiZWuXLiJAntitumor activity of celastrol nanoparticles in a xenograft retinoblastoma tumor modelInt J Nanomedicine2012723892398 doi:10.2147/IJN.S2994522661892
   PubMed Web of Science ®Google Scholar
• ShawPCLeeKMWongKBRecent advances in trichosanthin, a ribosome-inactivating protein with multiple pharmacological propertiesToxicon20054568368915804517
   PubMed Web of Science ®Google Scholar
• LuYZLiPFLiYZEnhanced anti-tumor activity of trichosanthin after combination with a human-derived cell-penetrating peptide, and a possible mechanism of activityFitoterapia201611218319027050721
   PubMed Web of Science ®Google Scholar
• ChenJLiSShenQFolic acid and cell-penetrating peptide conjugated PLGA–PEG bifunctional nanoparticles for vincristine sulfate deliveryEur J Pharm Sci20124743044322796217
   PubMed Web of Science ®Google Scholar
• AminAGali-MuhtasibHOckerMSchneider-StockROverview of major classes of plant-derived anticancer drugsInt J Biomed Sci2009511123675107
   PubMedGoogle Scholar
• BernabeuECagelMLagomarsinoEMorettonMChiappettaDAPaclitaxel: what has been done and the challenges remain aheadInt J Pharm201752647449528501439
   PubMed Web of Science ®Google Scholar
• FuHShiKHuGTumor-targeted paclitaxel delivery and enhanced penetration using TAT-decorated liposomes comprising redox-responsive poly(ethylene glycol)J Pharm Sci20151041160117325449709
   PubMed Web of Science ®Google Scholar
• Simón-GraciaLHuntHScodellerPiRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomesBiomaterials201610424725727472162
   PubMed Web of Science ®Google Scholar
• DuanZChenCQinJCell-penetrating peptide conjugates to enhance the antitumor effect of paclitaxel on drug-resistant lung cancerDrug Deliv20172475276428468542
   PubMed Web of Science ®Google Scholar
• GaneshTImproved biochemical strategies for targeted delivery of taxoidsBioorg Med Chem20071535373545
   Web of Science ®Google Scholar
• YoonHYKwakSSJangMHDocetaxel-loaded RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes: drug release, cytotoxicity, and antitumor efficacyInt J Pharm201752322923728341149
   PubMedGoogle Scholar
• ZhangJMWangLChanHFCo-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cellsSci Rep201774605728470171
   PubMed Web of Science ®Google Scholar
• ShahinMAhmedSKaurKLavasanifarADecoration of polymeric micelles with cancer-specific peptide ligands for active targeting of paclitaxelBiomaterials2011325123513321501865
   PubMed Web of Science ®Google Scholar
• HuQGaoXGuGGlioma therapy using tumor homing and penetrating peptide-functionalized PEG–PLA nanoparticles loaded with paclitaxelBiomaterials2013345640565023639530
   PubMed Web of Science ®Google Scholar
• KulhariHPoojaDShrivastavaSNaiduVGPeptide conjugated polymeric nanoparticles as a carrier for targeted delivery of docetaxelColloids Surf B Biointerfaces201411716617324632389
   PubMed Web of Science ®Google Scholar
• AlloattiDGianniniGVesciLCamptothecins in tumor homing via an RGD sequence mimeticBioorg Med Chem Lett2012226509651222959246
   PubMed Web of Science ®Google Scholar
• YangZLuoXZhangXLiuJJiangQTargeted delivery of 10-hydroxycamptothecin to human breast cancers by cyclic RGD-modified lipid-polymer hybrid nanoparticlesBiomed Mater2013802501223507576
   PubMed Web of Science ®Google Scholar